NPI registry status
Active
2026 NPPES data Low Vision Rehabilitation Optometrist NPI 1477046522 OD
Verify on CMS → Miriam Madry, OD
Low Vision Rehabilitation Optometrist in New York, New York.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 299 in Low Vision Rehabilitation Optometrist, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
2K
Medicare Part D claims · 374 beneficiaries · Low Vision Rehabilitation Optometrist avg: 296
Generic prescribing
32%
generic claims · 68% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
89.2/100
▲ 6 pts above national avg 83.5 · Exceptional
Industry payments
$776.07
35 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Miriam Madry, OD reported a CMS MIPS final score of 89.2/100 - above the 83.5 national average - and filed 2,328 Medicare Part D claims in 2023.
- 89.2/100
- MIPS score · +6 vs avg
- 2K
- Part D claims, 2023
- 32%
- generic prescribing
- $776.07
- industry payments (Sunshine Act)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Miriam Madry, OD's MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
89 ≥ 56th percentile 56% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Miriam Madry, OD sits
This provider among low vision rehabilitation optometrist peers
Across the 29 low vision rehabilitation optometrist providers who report both Medicare Part D prescribing and a MIPS quality score, Miriam Madry, OD writes more Part D claims than 90% of them and scores higher on MIPS quality than 62% - placing this provider in the high-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one low vision rehabilitation optometrist peer from a representative sample of 28; the gold marker is Miriam Madry, OD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
What does the federal data show about Miriam Madry, OD?
High performer (top quartile)Primary specialty
Low Vision Rehabilitation Optometrist
Medicare Part D claims
2,328 8× vs specialty avg
MIPS final score
89.2/100 5.7 pts vs avg
Specialty distribution in New York
How Low Vision Rehabilitation Optometrist compares to other specialties among New York providers
Medicare quality performance, MIPS
Miriam Madry, OD's 2023 MIPS final score plotted against the Low Vision Rehabilitation Optometrist national average
- MIPS Final Score
- 89.2/100
- vs 83.5 national avg · 2023 performance year
MIPS final score (Low Vision Rehabilitation Optometrist) - 89.2/100 vs national avg 83.5
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Miriam Madry, OD appears in the CMS NPPES registry as a Low Vision Rehabilitation Optometrist provider holding OD credentials at 147 W 142ND ST FL 1, New York, NY, 10030, with a listed phone of (212) 439-9600. NPI 1477046522 was issued on 06/13/2018.
Medicare Part D records for calendar year 2023 show 2,328 prescription claims written by this provider, covering 374 Medicare beneficiaries and totaling roughly $963K in drug spend, split 68% brand-name and 32% generic by claim count. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 89.2/100 for the 2023 performance year (Quality 94), compared with the 83.5 average among clinicians with a measured score.
Low Vision Rehabilitation Optometrist is a narrow specialty nationwide, with 299 enrolled providers across 39 states and an average of 296 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1477046522 |
|---|---|
| Specialty | Low Vision Rehabilitation Optometrist |
| Credentials | OD |
| Gender | Female |
| NPI Issued | 06/13/2018 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
89.2198
Final Score
Measured-score avg: 83.5
94.036
Quality
75
Promoting Interoperability
Reporting: Group practice
Hospital and facility affiliations
Facilities where Miriam Madry, OD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Maculacare PLLC
New York, NY
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Miriam Madry, OD. Source: openpaymentsdata.cms.gov.
Total received
$776
Largest payer
Alcon Vision LLC
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
License & disciplinary context - New York NYSBPMC 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 - they are NOT specific to Miriam Madry, OD. To verify Miriam Madry, OD's current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases
NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Brand-heavy
Miriam Madry, OD - brand share 68.0%
Low Vision Rehabilitation Optometrist average
68% brand-name claims vs 32% generic, on 2,328 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
2,328
Total Claims
$963K
Total Drug Cost
374
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 3,698
- Total Day Supply
- 107,316
- Brand vs Generic
- 68% brand / 32% generic
- Brand Drug Cost
- $939K
- Generic Drug Cost
- $25K
Patient Demographics
- Average Patient Age
- 75.4 years
- Avg HCC Risk Score
- 1.54
- Gender Split
- 68% female / 32% male
- Age Distribution
- <65: 24, 65-74: 159, 75-84: 141, 85+: 50
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Miriam Madry, OD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Latanoprost
Latanoprost
417 claims
- Restasis
Restasis
328 claims
- Lumigan
Lumigan
174 claims
- Vyzulta
Vyzulta
174 claims
- Xiidra 162
Xiidra
162 claims
- Dorzolamide-Timolol 155
Dorzolamide-Timolol
155 claims
- Combigan 123
Combigan
123 claims
- Cequa 122
Cequa
122 claims
| Drug | Claims |
|---|---|
| Latanoprost | 417 |
| Restasis Cyclosporine | 328 |
| Lumigan Bimatoprost | 174 |
| Vyzulta Latanoprostene Bunod | 174 |
| Xiidra Lifitegrast | 162 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 155 |
| Combigan Brimonidine Tartrate/Timolol | 123 |
| Cequa Cyclosporine | 122 |
| Rhopressa Netarsudil Mesylate | 89 |
| Rocklatan Netarsudil Mesylat/Latanoprost | 84 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
More Low Vision Rehabilitation Optometrist in NY →
All providers in New York →
Compare specialties →
Low Vision Rehabilitation Optometrist Overview
How Miriam Madry, OD fits within the Low Vision Rehabilitation Optometrist landscape nationally.
299
Low Vision Rehabilitation Optometrist Providers in US
39
States with Low Vision Rehabilitation Optometrist
296
Avg Claims per Provider
Miriam Madry, OD's 2,328 claims are above the specialty average of 296.
Nearby Low Vision Rehabilitation Optometrist Providers in New York
Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as Madry.
Dr. Aurora Axin Tussy
O.D., F.A.A.O.
Bronx, NY
Dr. Stephen Baker
O.D.
Watertown, NY
Dr. Jeffrey Calhoun
O.D.
Williamsville, NY
Dr. Christine Chea
O.D.
Brooklyn, NY
Dr. Emily Chu
O.D.
Forest Hills, NY
Compare Low Vision Rehabilitation Optometrist nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the New York medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Low Vision Rehabilitation Optometrist peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore New York
Frequently Asked Questions
What is Miriam Madry, OD's specialty? ▼
Miriam Madry, OD specializes in Low Vision Rehabilitation Optometrist and practices in New York, New York. Credentials: OD.
How much does Miriam Madry, OD prescribe under Medicare Part D? ▼
In 2023, Miriam Madry, OD wrote 2,328 Medicare Part D claims totaling $963K in drug costs for 374 beneficiaries.
What is Miriam Madry, OD's Medicare quality score? ▼
Miriam Madry, OD has a CMS MIPS Final Score of 89.2/100 (Quality: 94). The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Miriam Madry, OD located? ▼
Miriam Madry, OD is located at 147 W 142ND ST FL 1, New York, NY, 10030. Phone: (212) 439-9600.
What is Miriam Madry, OD's NPI number? ▼
Miriam Madry, OD's National Provider Identifier (NPI) is 1477046522, issued on 06/13/2018.
Does Miriam Madry, OD prescribe more brand-name or generic drugs? ▼
Miriam Madry, OD's prescribing is 68% brand-name and 32% generic drugs by claim count, with $939K in brand drug costs.
How many Low Vision Rehabilitation Optometrist providers are there in the US? ▼
There are 299 Low Vision Rehabilitation Optometrist providers across 39 states in the US. The average Low Vision Rehabilitation Optometrist provider writes 296 Medicare Part D claims per year.
What drugs does Miriam Madry, OD prescribe most often? ▼
Based on 2023 Medicare Part D data, Miriam Madry, OD's most frequently prescribed drugs include Latanoprost, Restasis, Lumigan. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Miriam Madry, OD accept Medicare? ▼
Miriam Madry, OD appears in CMS Medicare data with 2,328 Part D claims and 374 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Miriam Madry, OD's credentials? ▼
Miriam Madry, OD's NPI is 1477046522 with credentials OD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.